Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 991.00K | $ 970.00K | $ 528.00K | $ 928.00K | $ 177.00K |
Total Assets | $ 91.61M | $ 89.33M | $ 80.20M | $ 80.26M | $ 74.85M |
Total Debt | $ 27.96M | $ 25.38M | $ 25.43M | $ 27.80M | $ 24.65M |
Net Debt | $ 26.97M | $ 24.41M | $ 24.91M | $ 26.87M | $ 24.47M |
Total Liabilities | $ 35.18M | $ 33.12M | $ 29.36M | $ 33.11M | $ 28.71M |
Stockholders Equity | $ 56.43M | $ 56.21M | $ 50.84M | $ 47.15M | $ 46.14M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |